mangostin and Leukemia--Myeloid--Acute

mangostin has been researched along with Leukemia--Myeloid--Acute* in 1 studies

Other Studies

1 other study(ies) available for mangostin and Leukemia--Myeloid--Acute

ArticleYear
Dietary γ-mangostin triggers immunogenic cell death and activates cGAS signaling in acute myeloid leukemia.
    Pharmacological research, 2023, Volume: 197

    Immunogenic cell death (ICD), one of cell-death types through release of damage-associated molecular patterns from dying tumor cells, activates tumor-specific immune response and elicits anti-tumor immunity by traditional radiotherapy and chemotherapy. However, whether natural products could induce ICD in leukemia is not elucidated. Here, we report dietary γ-mangostin eradicates murine primary leukemic cells and prolongs the survival of leukemic mice. As well, it restrains primary leukemic cells and CD34

    Topics: Animals; Chemokines; Diet; Humans; Immunogenic Cell Death; Leukemia, Myeloid, Acute; Mice; Tumor Microenvironment

2023